Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Jiangdong Huo^{1

2

3}, Audrey Le Bas^{2

3}, Reinis R Ruza², Helen M E Duyvesteyn², Halina Mikolajek⁴, Tomas Malinauskas², Tiong Kit Tan⁵, Pramila Rijal^{5

6}, Maud Dumoux¹, Philip N Ward^{2

3}, Jingshan Ren², Daming Zhou², Peter J Harrison^{2

3}, Miriam Weckener¹, Daniel K Clare⁴, Vinod K Vogirala⁴, Julika Radecke⁴, Lucile Moynié¹, Yuguang Zhao², Javier Gilbert-Jaramillo⁷, Michael L Knight⁷, Julia A Tree⁸, Karen R Buttigieg⁸, Naomi Coombes⁸, Michael J Elmore⁸, Miles W Carroll⁸, Loic Carrique², Pranav N M Shah², William James⁷, Alain R Townsend^{5

6}, David I Stuart^{2

4}, Raymond J Owens^{9

10

11}, James H Naismith^{12

13

14}

Affiliations

¹ Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
² Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
³ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK.
⁴ Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
⁵ MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
⁶ Centre for Translational Immunology, Chinse Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
⁷ Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
⁸ National Infection Service, Public Health England, Porton Down, Salisbury, UK.
⁹ Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
¹⁰ Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. raymond.owens@rc-harwell.ac.uk.
¹¹ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
¹² Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.
¹³ Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. naismith@strubi.ox.ac.uk.
¹⁴ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.

PMID: 33060850
PMCID: PMC7557317
DOI: 10.1038/s41594-020-00527-9

Published Erratum

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Jiangdong Huo et al. Nat Struct Mol Biol. 2020 Nov.

. 2020 Nov;27(11):1094.

doi: 10.1038/s41594-020-00527-9.

Authors

Affiliations

¹ Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
² Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
³ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK.
⁴ Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
⁵ MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
⁶ Centre for Translational Immunology, Chinse Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
⁷ Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
⁸ National Infection Service, Public Health England, Porton Down, Salisbury, UK.
⁹ Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
¹⁰ Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. raymond.owens@rc-harwell.ac.uk.
¹¹ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
¹² Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.
¹³ Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. naismith@strubi.ox.ac.uk.
¹⁴ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.

PMID: 33060850
PMCID: PMC7557317
DOI: 10.1038/s41594-020-00527-9

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Huo J, Le Bas A, Ruza RR, Duyvesteyn HME, Mikolajek H, Malinauskas T, Tan TK, Rijal P, Dumoux M, Ward PN, Ren J, Zhou D, Harrison PJ, Weckener M, Clare DK, Vogirala VK, Radecke J, Moynié L, Zhao Y, Gilbert-Jaramillo J, Knight ML, Tree JA, Buttigieg KR, Coombes N, Elmore MJ, Carroll MW, Carrique L, Shah PNM, James W, Townsend AR, Stuart DI, Owens RJ, Naismith JH. Huo J, et al. Nat Struct Mol Biol. 2020 Sep;27(9):846-854. doi: 10.1038/s41594-020-0469-6. Epub 2020 Jul 13. Nat Struct Mol Biol. 2020. PMID: 32661423

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Affiliations

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Authors

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous